Human cholinergic basal forebrain: Chemoanatomy and neurologic dysfunction

Journal of Chemical Neuroanatomy

Volumn 26, Issue 4, 2003, Pages 233-242

  Mufson, Elliott J ^a   Ginsberg, Stephen D ^b   Ikonomovic, Milos D ^c   DeKosky, Steven T ^c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoanatomy; Human cholinergic basal forebrain; Neurologic dysfunction

Indexed keywords

4 AMINOBUTYRIC ACID; CALBINDIN; CALCIUM BINDING PROTEIN; CHOLINE ACETYLTRANSFERASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GALANIN; GLUTAMATE RECEPTOR; MUSCARINIC RECEPTOR; NERVE GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ATTENTION; CELL COUNT; CHOLINERGIC BASAL FOREBRAIN; CHOLINERGIC SYSTEM; COGNITION; CONFERENCE PAPER; ENZYME ACTIVITY; FOREBRAIN; HIPPOCAMPUS; HUMAN; INTERNEURON; NEOCORTEX; NERVE CELL; NERVE CELL NECROSIS; NERVE PROJECTION; NEUROANATOMY; NEUROLOGIC DISEASE; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0347914568     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(03)00068-1     Document Type: Conference Paper

References (101)

1. Arendt T., Bigl V., Tennstedt A., Arendt A. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience. 14:1985;1-14.
2. Armstrong D.M., Ikonomovic M.D., Mizukami K., Mishizin A., Sheffield R., Wolfe B.B. Glutamatergic mechanisms in Alzheimer's disease. Marwah J., Teitelbaum H. Advances in Neurodegenerative Disorder: Alzheimer's and Aging. 1998;71-97 Prominent Press, Scottsdale, AZ.
3. Bennett D.A., Shannon K.M., Beckett L.A., Goetz C.G., Wilson R.S. Metric properties of nurses' ratings of parkinsonian signs with a modified unified Parkinson's disease rating scale. Neurology. 49:1997;1580-1587.
4. Bennett D.A., Shannon K.M., Beckett L.A., Wilson R.S. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J. Gerontol. Ser. A, Biol. Sci. Med. Sci. 54:1999;M191-M196.
5. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., Bach J. Natural history of mild cognitive impairment in older persons. Neurology. 59:2002;198-205.
6. Benzing W.C., Mufson E.J. Increased number of NADPH-d positive neurons within the substantia innominata in Alzheimer's disease. Brain Res. 670:1995;351-355.
7. Benzing W.C., Kordower J.H., Mufson E.J. Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes. J. Comp. Neurol. 336:1993;31-39.
8. Blurton-Jones M.M., Roberts J.A., Tuszynski M.H. Estrogen receptor immunoreactivity in the adult primate brain: neuronal distribution and association with p75, TrkA, and choline acetyltransferase. J. Comp. Neurol. 405:1999;529-542.
9. Boissiere F., Faucheux B., Ruberg M., Agid Y., Hirsch E.C. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp. Neurol. 145:1997;245-252.
10. Bonner T.I., Buckley N.J., Young A.C., Brann M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science. 237:1987;527-532.
11. Bowser R., Kordower J.H., Mufson E.J. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol. 7:1997;723-730.
12. Braak H., Braak E. Neuropathological staging of Alzheimer's disease. Acta Neuropathol. 82:1991;239-259.
13. Candy J.M., Perry R.H., Thompson J.E., Johnson M., Oakley A.E. Neuropeptide localization in the substantia nigra innominata and adjacent regions of the human brain. J. Anatomy. 140:1985;309-327.
14. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273:1988;543-557.
15. Chu Y., Cochran E.J., Beckett L.A., Bennett D.A., Mufson E.J., Kordower J.H. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 437:2001;296-307.
16. Davis K.L., Mohs R.C., Marin D., Purohit D.P., Perl D.P., Lantz M., Austin G., Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. J. Am. Med. Assoc. 281:1999;1401-1406.
17. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. USA. 88:1991;7797-7801.
18. de Lacalle S., Saper C.B. The cholinergic system in the primate brain: basal forebrain and pontine-tegmental cell groups. Bloom F.E., Bjorklund A., Hokfelt T. The Primate Nervous System, Part I. 1997;217-262 Elsevier, The Netherlands.
19. de Lacalle S., Iraizoz I., Ma Gonzalo L. Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging. Neuroscience. 43:1991;445-456.
20. de Lacalle S., Lim C., Sobreviela T., Mufson E.J., Hersh L.B., Saper C.B. Cholinergic innervation in the human hippocampal formation including the entorhinal cortex. J. Comp. Neurol. 345:1994;321-344.
21. DeKosky, S.T., Harbaugh, R.E., Schmitt, F.A., Bakay, R.E., Knopman, H.C., Reeder, T.M., Schetter, A.G., Senter, H.J., Markesbery, W.R., Group, I.B.S., 1992. Cortical biopsy in Alzheimer's Disease: diagnostic accuracy and neurochemical, neuropathological and cogntive correlations. Ann. Neurol. 32, 625-632.
22. DeKosky S.T., Ikonomovic M.D., Styren S., Beckett L., Wisniewski S., Bennett D.A., Cochran E.J., Kordower J.H., Mufson E.J. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51:2002;145-155.
23. Desjardins C., Parent A. Distribution of somatostatin immunoreactivity in the forebrain of the squirrel monkey: basal ganglia and amygdala. Neuroscience. 47:1992;115-133.
24. Ellison D.W., Kowall N.W., Martin J.B. Subset of neurons characterized by the presence of NADPH-diaphorase in human substantia innominata. J. Comp. Neurol. 260:1987;233-245.
25. Fonnum F. A rapid radiochemical method for the determination of choline aectyltransferase. J. Neurochem. 24:1975;407-409.
26. Geula C., Schatz C.R., Mesulam M.M. Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience. 54:1993;461-476.
27. Geula C., Bu J., Nagykery N., Scinto L.F., Chan J., Joseph J., Parker R., Wu C.K. Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss. J. Comp. Neurol. 455:2003;249-259.
28. Gilmor M.L., Erickson J.D., Varoqui H., Hersh L.B., Bennett D.A., Cochran E.J., Mufson E.J., Levey A.I. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 411:1999;693-704.
29. Ginsberg S.D., Che S. RNA amplification in brain tissues. Neurochem. Res. 27:2002;981-992.
30. Ginsberg S.D., Schmidt M.L., Crino P.B., Eberwine J.H., Lee V.M.-Y., Trojanowski J.Q. Molecular pathology of Alzheimer's disease and related disorders. Peters A., Morrison J.H. Cerebral Cortex. 1999;603-653 Kluwer Academic/Plenum, New York.
31. Haber S., Elde R. The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system: an immunohistochemical study. Neuroscience. 7:1982;1049-1095.
32. Haber S.N., Watson S.J. The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain. Neuroscience. 14:1985;1011-1024.
33. Hefti F. Is Alzheimer's disease caused by lack of nerve growth factor. Ann. Neurol. 13:1983;109-110.
34. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6:1986;2155-2162.
35. Hefti F., Mash D.C. Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease. Neurobiol. Aging. 10:1989;75-87.
36. Hemby S.E., Trojanowski J.Q., Ginsberg S.D. Neuron-specific age-related decreases in dopamine receptor subtype mRNAs. J. Comp. Neurol. 456:2003;176-183.
37. Hulme E.C., Birdsall N.J., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
38. Ikonomovic M.D., Armstrong D.M. Distribution of AMPA receptor subunits in the nucleus basalis of Meynert in aged humans: implications for selective neuronal degeneration. Brain Res. 716:1996;229-232.
39. Ikonomovic M.D., Nocera R., Mizukami K., Armstrong D.M. Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert. Exp. Neurol. 166:2000;363-375.
40. Ikonomovic M.D., Mufson E.J., Woo J., Cochran E.J., Bennett D.A., DeKosky S.T. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J. Alz. Dis. 5:2003;39-48.
41. Ishunina T.A., Swaab D.F. Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol. Aging. 22:2001;417-426.
42. Kitt C.A., Mitchell S.J., DeLong M.R., Wainer B.H., Price D.L. Fiber pathways of basal forebrain cholinergic neurons in monkeys. Brain Res. 406:1987;192-206.
43. Koike S., Sakai M., Muramatsu M. Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res. 15:1987;2499-2513.
44. Kolliker A. Handbuch der Gewebelehre des Menschen. Nervensystem. 1896;Engelmann, Leipzig.
45. Kordower J.H., Mufson E.J. Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys. J. Comp. Neurol. 294:1990;281-292.
46. Kordower J.H., Bartus R.T., Bothwell M., Schatteman G., Gash D.M. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes. J. Comp. Neurol. 277:1988;465-486.
47. Kordower J.H., Bartus R.T., Marciano F.F., Gash D.M. Telencephalic cholinergic system of the New World non-human primate (Cebus apella): morphological and cytoarchitectonic assessment and analysis of the projection to amygdala. J. Comp. Neurol. 279:1989;528-545.
48. Kordower J.H., Gash D.M., Bothwell M., Hersh L., Mufson E.J. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol. Aging. 10:1989;287-294.
49. Kordower J.H., Le H.K., Mufson E.J. Galanin-immunoreactivity in the primate central nervous system. J. Comp. Neurol. 319:1992;479-500.
50. Kordower J.H., Chu Y., Stebbins G.T., DeKosky S.T., Cochran E.J., Bennett D.A., Mufson E.J. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49:2001;202-213.
51. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA. 93:1996;5925-5930.
52. Kus, L., Borys, E., Levey, A.I., Emborg, M., Kordower, J.H., Mufson, E.J., 2003. High-affinity choline transporter immunoreactive profiles in monkey and human brain. Soc. Neurosci. Abstr.
53. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11:1991;3218-3226.
54. Lowes-Hummel P., Gertz H., Ferszt R., Cervos-Navarro J. The basal nucleus of Meynert revised: the nerve cell number decreases with age. Arch. Gerontol. Geriatrics. 8:1989;21-27.
55. Mann D.M.A., Yates P.O., Marcyniuk B. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech. Ageing Dev. 25:1984;189-204.
56. Mash D.C., Potter L.T. Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain. Neuroscience. 19:1986;551-564.
57. Mash D.C., Flynn D.D., Potter L.T. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science. 228:1985;1115-1117.
58. McGeer P.L., McGeer E.G., Suzuki J., Dolman C.E., Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology. 34:1984;741-745.
59. Mesulam M.M., Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J. Comp. Neurol. 275:(2):1988;216-240.
60. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214:1983;170-197.
61. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience. 12:1984;669-686.
62. Mesulam M.M., Mufson E.J., Wainer B. Three-dimensional representation and cortical projection topography of the nucleus basalis (Ch4) in the macaque: concurrent demonstration of choline acetyltransferase and retrograde transport with a stabilized tetramethylbenzidine method for horseradish peroxidase. Brain Res. 367:1986;301-308.
63. Meynert T. The brains of mammals. Stricker S. A Manual of Histology. 1872;650-766 William Wood, New York. J.J. Putnam (Translator).
64. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
65. Mufson E.J., Kordower J.H. Nerve growth factor in Alzheimer's disease. Peters A.A., Morrison J.H. Cerebral Cortex. 1999;681-731 Kluwer Academic/Plenum Press, New York.
66. Mufson E.J., Kordower J.H. Cholinergic basal forebrain systems in the primate central nervous system: anatomy, connectivity, neurochemistry, aging, dementia and experimental therapeutics. Hof P.R., Moobs C.V. Functional Neurobiology of Aging. 2000;243-276 Academic Press, San Diego.
67. Mufson E.J., Benoit R., Mesulam M.M. Immunohistochemical evidence for a possible somatostatin containing amygdalo-striatal pathway in normal and Alzheimer's disease brain. Brain Res. 453:1988;117-128.
68. Mufson E., Bothwell M., Kordower J.H. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp. Neurol. 105:1989;221-232.
69. Mufson E.J., Bothwell M., Hersh L.B., Kordower J.H. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J. Comp. Neurol. 285:1989;196-217.
70. Mufson E.J., Bothwell M., Kordower J.H. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across regions of basal forebrain. Exp. Neurol. 105:1989;221-232.
71. Mufson E.J., Kordower J.H. Cortical neurons express nerve growth factor in advanced age and Alzheimer's disease. Proc. Natl. Acad. Sci. 89:1992;569-573.
72. Mufson E.J., Cochran E., Benzing W.C., Kordower J.H. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia. 4:1993;237-250.
73. Mufson E.J., Li J.-M., Sobreviela T., Kordower J.H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport. 8:1996;25-29.
74. Mufson E.J., Lavine N., Jaffar S., Kordower J.H., Quirion R., Saragovi H.U. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:1997;91-103.
75. Mufson E.J., Jaffar S., Levey A.I. m2 muscarinic acetylcholine receptor immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya. J. Comp. Neurol. 392:1998;313-329.
76. Mufson E.J., Chen E.Y., Cochran E.J., Beckett L.A., Bennett D.A., Kordower J.H. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp. Neurol. 158:1999;469-490.
77. Mufson E.J., Kroin J.S., Sendera T.J., Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57:1999;451-484.
78. Mufson E.J., Deecher D.C., Basile M., Izenwasser S., Mash D.C. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology. 39:2000;1404-1412.
79. Mufson E.J., Ma S.J., Cochran E.J., Bennett D.A., Beckett L.A., Jaffar S., Saragovi H.U., Kordower J.H. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 427:2000;19-30.
80. Mufson E.J., Counts S.E., Ginsberg S.D. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem. Res. 27:2002;1033-1046.
81. Mufson E.J., Ma S.Y., Dills J., Cochran E.J., Leurgans S., Wuu J., Bennett D.A., Jaffar S., Gilmor M.L., Levey A.I., Kordower J.H. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 443:2002;136-153.
82. NIA, 1997. National Institute on Aging and Reagan Institute working group on diagnosis criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of AD. Neurobiol. Aging 18, S1-S3.
83. Osterlund M.K., Gustafsson J.A., Keller E., Hurd Y.L. Estrogen receptor beta (ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERα mRNA. J. Clin. Endocrinol. Metab. 85:2000;3840-3846.
84. Pellegrini-Giampietro D.E., Zukin R.S., Bennett M.V., Cho S., Pulsinelli W.A. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. USA. 89:1992;10499-10503.
85. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1:1977;189.
86. Pohorecki R., Head R., Domino E.F. Effects of selected muscarinic cholinergic antagonists on [3H]acetylcholine release from rat hippocampal slices. J. Pharmacol. Exp. Ther. 244:1988;213-217.
87. Schatteman G.C., Gibbs L., Lanaham A.A., Claude P., Bothwell M. Expression of NGF receptor in the developing and adult primate central nervous system. J. Neurosci. 8:1988;860-873.
88. Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J.M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 46:1996;1580-1584.
89. Selden N.R., Gitelman D.R., Salamon-Murayama N., Parrish T.B., Mesulam M.M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 121:1998;2249-2257.
90. Sendera T.J., Kordower J.H., Mufson E.J. Estrogen receptor containing neurons in the primate brain: association with choline acetyltransferase, GABAergic markers and substance P. Soc. Neurosci. Abstr. 25:1999;2119.
91. Sherwin B.B. Estrogen and cognitive function in women. Endocrinology. 24:2003;123-151.
92. Shumaker S.A., Legault C., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N. III, Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. J. Am. Med. Assoc. 289:2003;2651-2662.
93. Strada O., Hirsch E.C., Javoy-Agid F., Lehericy S., Ruberg M., Hauw J.-J., Agid Y. Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain. J. Neurosci. 12:1992;4766-4774.
94. Szenborn M. Neuropathologic study of the nucleus basalis of Meynert in mature and old aging. Pathol. Pol. 44:1993;211-216.
95. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
96. Vogels O.J., Broere C.A., ter Laak H.J., ten Donkelaar H.J., Nieuwenhuys R., Schulte B.P. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging. 11:1990;3-13.
97. Walker L.C., Rance N.E., Price D.L., Young W.S. Galanin mRNA in the nucleus basalis of Meynert complex of baboons and humans. J. Comp. Neurol. 303:1991;113-120.
98. West M.J., Ostergaard K., Andreassen O.A., Finsen B. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J. Comp. Neurol. 370:1996;11-22.
99. Whitehouse P., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R.J. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
100. Wilcock G.K., Esiri M.M., Bowen D.M., Smith C.C.T. Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57:1982;407-417.
101. Wu C.K., Mesulam M.M., Geula C. Age-related loss of calbindin from human basal forebrain cholinergic neurons. Neuroreport. 8:1997;2209-2213.